Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. 4 Grant or award Director acquired 237 shares (grant or award)
  2. 4 Grant or award Director acquired 153 shares (grant or award)
  3. 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $136.85 ($2,736,945)
  4. 4 Grant or award Director acquired 148 shares (grant or award)
  5. 4 Open-market sale Chief Growth Officer sold 7,873 shares at $146.39 ($1,152,528)
  6. 4 Open-market sale Chief Financial Officer sold 23,619 shares at $146.39 ($3,457,585)
  7. 4 Planned sale Chief Financial Officer sold 4,100 shares at an average $93.34 ($382,679)
  8. 4 Planned sale Chief Executive Officer sold 61,452 shares at an average $97.74 ($6,006,378)
  9. 4 Planned sale Chief Executive Officer sold 5,000 shares at $85.02 ($425,098)
  10. 4 Planned sale Chief Financial Officer sold 7,900 shares at $85.01 ($671,579)
  11. 4 Grant or award Director acquired 276 shares (grant or award)
  12. 4 Grant or award Director acquired 427 shares (grant or award)
  13. 4 Grant or award Director acquired 268 shares (grant or award)
  14. 4 Grant or award Director acquired 5,491 shares (grant or award)
  15. 4 Grant or award Director acquired 5,491 shares (grant or award)
  16. 4 Grant or award Director acquired 5,491 shares (grant or award)
  17. 4 Grant or award Director acquired 5,491 shares (grant or award)
  18. 4 Open-market sale Chief Growth Officer sold 1,491 shares at $61.08 ($91,070)
  19. 4 Grant or award Chief Executive Officer acquired 31,055 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 1 of 6 · 115 filings